Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
- Resource Type
- Correspondence
- Authors
- Northend, Michael ; Wilson, William; Osborne, Wendy; Fox, Christopher P.; Davies, Andrew J.; El-Sharkawi, Dima; Phillips, Elizabeth H.; Sim, Hau Wui; Sadullah, Shalal; Shah, Nimish; Peng, Ying Ying; Qureshi, Iman; Addada, Juanah; Mora, Rocio Figueroa; Phillips, Neil; Kuhnl, Andrea; Davies, Elizabeth; Wrench, David; McKay, Pamela; Karpha, Indrani; Cowley, Anna; Karim, Richard; Challenor, Sarah; Singh, Vikram; Burton, Cathy; Auer, Rebecca; Williams, Chris; Cunningham, Joel; Broom, Angus; Arasaretnam, Anita; Roddie, Claire; Menne, Tobias; Townsend, William
- Source
- In Blood Advances 10 May 2022 6(9):2920-2926
- Subject
- Language
- ISSN
- 2473-9529